Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Hamburg - Delayed Quote EUR

Vertex Pharmaceuticals Inc (VX1.HM)

431.15
+5.30
+(1.24%)
At close: April 23 at 5:25:20 PM GMT+2
Loading Chart for VX1.HM
  • Previous Close 425.85
  • Open 0.00
  • Bid --
  • Ask --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 483.05
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 5, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: VX1.HM

View More

Performance Overview: VX1.HM

Trailing total returns as of 4/23/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

VX1.HM
10.79%
S&P 500 (^GSPC)
8.60%

1-Year Return

VX1.HM
15.19%
S&P 500 (^GSPC)
6.02%

3-Year Return

VX1.HM
66.37%
S&P 500 (^GSPC)
25.85%

5-Year Return

VX1.HM
72.53%
S&P 500 (^GSPC)
92.15%

Compare To: VX1.HM

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VX1.HM

View More

Valuation Measures

Annual
As of 4/22/2025
  • Market Cap

    109.55B

  • Enterprise Value

    105.76B

  • Trailing P/E

    --

  • Forward P/E

    27.86

  • PEG Ratio (5yr expected)

    1.34

  • Price/Sales (ttm)

    11.47

  • Price/Book (mrq)

    7.68

  • Enterprise Value/Revenue

    11.05

  • Enterprise Value/EBITDA

    250.31

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: VX1.HM

View More

Company Insights: VX1.HM

Research Reports: VX1.HM

View More